U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
NEW DRUG FOR ALZHEIMER’S. A GROUNDBREAKING ADVANCEMENT TO SLOW THE PROGRESSION, PROGRESSION? EXCUSE ME OF THIS DISEASE. HERE TO EXPLAIN MORE ON WHAT THIS MEANS FOR PATIENTS. IS DOCTOR PETER GLOBUS ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...